Our Pricing

Does Wegovy Work? Clinical Evidence and Real-World Results

Published on: June 03, 2026

Does Wegovy work for weight loss? Clinical evidence from the STEP trials demonstrates that Wegovy (semaglutide 2.4mg) delivers significant weight reduction, with participants losing an average of 15% of their body weight over 68 weeks[1]. As a UK-registered pharmacy with superintendent pharmacist Tarun Kumar (GPhC 2233073) overseeing clinical care, Cured Pharmacy provides access to genuine Wegovy at the cheapest UK price from £69.00, with all prescriptions subject to clinical assessment by our UK-registered prescribers.

Does Wegovy Work? Understanding the Clinical Evidence

Does Wegovy work according to rigorous scientific research? The STEP clinical trial programme provides compelling evidence. In the pivotal STEP 1 trial involving 1,961 adults with obesity, participants taking Wegovy achieved an average weight loss of 14.9% of their initial body weight compared to 2.4% with placebo over 68 weeks[1]. This represents a statistically significant difference that has been replicated across multiple international studies.

The mechanism behind why Wegovy works centres on semaglutide's action as a GLP-1 receptor agonist. It mimics the naturally occurring hormone glucagon-like peptide-1, which regulates appetite and food intake[2]. By activating GLP-1 receptors in the brain, Wegovy reduces hunger signals and increases feelings of fullness, leading to reduced calorie consumption. Additionally, semaglutide slows gastric emptying, prolonging satiety after meals and supporting sustained weight reduction when combined with lifestyle modifications.

MHRA Approval and UK Regulatory Status

The Medicines and Healthcare products Regulatory Agency (MHRA) licensed Wegovy in the UK following comprehensive review of clinical trial data demonstrating both efficacy and safety. NICE (National Institute for Health and Care Excellence) subsequently recommended Wegovy for NHS use in specific patient populations, further validating the question of does Wegovy work with institutional endorsement[3]. At Cured Pharmacy, we supply only genuine MHRA-licensed Wegovy, ensuring patients receive authentic medication with full regulatory approval.

How Well Does Wegovy Work Compared to Other Treatments?

When evaluating does Wegovy work relative to alternative weight loss interventions, comparative data shows superior outcomes. Head-to-head studies demonstrate that semaglutide 2.4mg produces greater weight reduction than liraglutide 3mg (Saxenda), with Wegovy users losing approximately 5-7% more body weight on average[4]. Compared to orlistat, which typically achieves 3-5% weight loss, Wegovy's efficacy profile is substantially more robust.

The durability of weight loss with Wegovy also distinguishes it from many alternatives. In the STEP 4 trial, participants who continued Wegovy maintained their weight loss, while those switched to placebo regained approximately two-thirds of the weight they had lost[1]. This evidence suggests that does Wegovy work for long-term weight management depends on continued treatment, as the medication supports sustained appetite regulation rather than providing a temporary intervention.

Does Wegovy Work for Everyone? Patient-Specific Factors

Does Wegovy work equally across all patient populations? Clinical trial data reveals variability in individual responses. While the average weight loss in STEP trials was approximately 15%, individual results ranged from minimal response to over 20% body weight reduction[1]. Factors influencing efficacy include baseline BMI, adherence to the prescribed dose escalation schedule, concurrent lifestyle modifications, and individual metabolic characteristics.

Certain patient groups demonstrate particularly strong responses. In the STEP 2 trial focusing on individuals with type 2 diabetes, Wegovy still achieved meaningful weight loss averaging 9.6% compared to 3.4% with placebo, though slightly less than in participants without diabetes[5]. Age, gender, and ethnicity show minimal impact on overall efficacy, though individual variation remains significant. At Cured Pharmacy, our UK-registered prescribers assess each patient's suitability during the clinical consultation, ensuring Wegovy is appropriate for your specific circumstances.

Realistic Expectations and Timeline

Understanding the timeline for does Wegovy work requires realistic expectations. Weight loss typically begins within the first 4-8 weeks, with gradual dose escalation over 16-20 weeks to reach the maintenance dose of 2.4mg weekly. Maximum weight reduction generally occurs between weeks 60-68 of continuous treatment[1]. Patients should anticipate steady, progressive weight loss rather than rapid dramatic changes, with the most substantial reductions occurring during months 4-12 of therapy.

Does Wegovy Work Without Diet and Exercise?

Does Wegovy work as a standalone intervention without lifestyle changes? While semaglutide produces weight loss through pharmacological appetite suppression, clinical trials required participants to follow reduced-calorie diets and increase physical activity[1]. The medication enhances adherence to dietary modifications by reducing hunger and cravings, making calorie restriction more sustainable. Wegovy is licensed as an adjunct to lifestyle intervention, not a replacement for healthy behaviours.

Real-world evidence suggests that patients who combine Wegovy with structured dietary guidance and regular physical activity achieve superior outcomes compared to those relying solely on medication. The synergistic effect of pharmacotherapy and lifestyle modification addresses weight management through multiple mechanisms—hormonal appetite regulation via semaglutide, plus direct calorie reduction and increased energy expenditure through behavioural changes. At Cured Pharmacy, we provide guidance on optimising lifestyle factors alongside your Wegovy prescription to maximise treatment effectiveness.

Does Wegovy Work Long-Term? Maintenance and Sustainability

Does Wegovy work for sustained weight management beyond initial loss? The STEP 4 withdrawal trial provides critical insight: participants who discontinued Wegovy after 20 weeks regained 6.9% body weight over the subsequent 48 weeks, while those continuing treatment lost an additional 7.9%[1]. This demonstrates that semaglutide's effects are treatment-dependent, requiring ongoing administration to maintain appetite suppression and weight stability.

Long-term safety data extending to 104 weeks confirms that Wegovy maintains efficacy without diminishing effect over time, with no unexpected safety signals emerging with prolonged use[6]. However, patients must understand that does Wegovy work permanently depends on continued treatment. Discontinuation typically results in gradual weight regain as appetite-regulating hormones return to baseline levels. The decision to continue Wegovy long-term should be made collaboratively with your prescriber, weighing ongoing benefits against treatment costs and individual health goals.

Managing Side Effects While Maintaining Efficacy

Does Wegovy work despite gastrointestinal side effects? Nausea, vomiting, and diarrhoea are common, particularly during dose escalation, affecting approximately 40-50% of users[2]. These symptoms typically diminish over 4-8 weeks as tolerance develops. The gradual dose escalation protocol minimises side effect severity while maintaining therapeutic efficacy. Most patients who experience initial gastrointestinal symptoms can continue treatment successfully, with side effects rarely necessitating discontinuation in clinical trials.

Does Wegovy Work at Cured Pharmacy? Access and Support

Does Wegovy work when prescribed through Cured Pharmacy? We supply only genuine MHRA-licensed Wegovy at the cheapest UK price from £69.00, with £20 off your first order using code Weightlossnew. Every prescription requires clinical assessment by our UK-registered prescribers, ensuring suitability and safety. Our transparent pricing model shows costs upfront before consultation, eliminating hidden fees common at other providers.

Cured Pharmacy (GPhC Registration Number 9012511) operates under the clinical oversight of superintendent pharmacist Tarun Kumar (GPhC 2233073), ensuring pharmaceutical excellence and regulatory compliance. We provide discreet packaging, next-day delivery options, and ongoing clinical support throughout your treatment journey. Does Wegovy work for your specific weight loss goals? Complete our online consultation to determine eligibility and receive expert guidance on optimising your treatment outcomes with genuine UK-licensed medication.

Scientific References

1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 13 August 2026]
2. Blundell, J., Finlayson, G., Axelsen, M., Flint, A., Gibbons, C., Kvist, T., & Hjerpsted, J. B. (2017). Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism, 19(9), 1242-1251. [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. [accessed 13 August 2026]
4. Rubino, D. M., Greenway, F. L., Khalid, U., O'Neil, P. M., Rosenstock, J., Sørrig, R., ... & Garvey, W. T. (2022). Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes. JAMA, 327(2), 138-150. [accessed 13 August 2026]
5. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 13 August 2026]
6. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wadden, T. A. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.